Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

NVZMYNVZMY
Showing 8 of 13 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in Novonesis Novozymes B

RHUMBLINE ADVISERS holds 12,425 shares of NVZMY (Novonesis Novozymes B), worth $785,747 as of 2026-Q2. The position was increased (+23.4% shares). NVZMY represents 0.0% of RHUMBLINE ADVISERS's portfolio.

Current Value

$785,747

Current Shares

12,425

Total Value Change

+$52,982

Total Shares Change

+2,249

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12,425
+23.4%
$785,7470.0%$62.92
30
2026-Q1
Increased
10,073
+0.6%
$601,9960.0%$59.45
24
2025-Q4
Decreased
10,013
-2.1%
$637,0190.0%$62.54
0
2025-Q3
Decreased
10,232
-2.6%
$625,4770.0%$60.09
0
2025-Q2
Increased
10,505
+0.2%
$752,5710.0%$70.43
25
2025-Q1
Increased
10,487
+1.3%
$612,5370.0%$56.84
25
2024-Q4
Increased
10,355
+1.8%
$585,4630.0%$55.02
25
2024-Q3
Increased
10,176
+17.9%
$732,7650.0%$70.08
29

Other major holders of NVZMY: HARDING LOEVNER LP, CAPTRUST FINANCIAL ADVISORS, PNC FINANCIAL SERVICES GROUP, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used